These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24452387)

  • 41. RhoA/Rock2/Limk1/cofilin1 pathway is involved in attenuation of neuronal dendritic spine loss by paeonol in the frontal cortex of D-galactose and aluminum‑induced Alzheimer's disease‑like rat model.
    Han F; Xu H; Shen JX; Pan C; Yu ZH; Chen JJ; Zhu XL; Cai YF; Lu YP
    Acta Neurobiol Exp (Wars); 2020; 80(3):225-244. PubMed ID: 32990282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of Rho GTPases in the morphogenesis and motility of dendritic spines.
    Tashiro A; Yuste R
    Methods Enzymol; 2008; 439():285-302. PubMed ID: 18374172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Semaphorin3F Drives Dendritic Spine Pruning Through Rho-GTPase Signaling.
    Duncan BW; Mohan V; Wade SD; Truong Y; Kampov-Polevoi A; Temple BR; Maness PF
    Mol Neurobiol; 2021 Aug; 58(8):3817-3834. PubMed ID: 33856648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasticity of dendritic spines: Molecular function and dysfunction in neurodevelopmental disorders.
    Nishiyama J
    Psychiatry Clin Neurosci; 2019 Sep; 73(9):541-550. PubMed ID: 31215705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thin, stubby or mushroom: spine pathology in Alzheimer's disease.
    Tackenberg C; Ghori A; Brandt R
    Curr Alzheimer Res; 2009 Jun; 6(3):261-8. PubMed ID: 19519307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models.
    Wang D; Fu Q; Zhou Y; Xu B; Shi Q; Igwe B; Matt L; Hell JW; Wisely EV; Oddo S; Xiang YK
    J Biol Chem; 2013 Apr; 288(15):10298-307. PubMed ID: 23430246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease.
    Mi Z; Abrahamson EE; Ryu AY; Fish KN; Sweet RA; Mufson EJ; Ikonomovic MD
    Neurobiol Aging; 2017 Jul; 55():159-166. PubMed ID: 28259365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
    Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
    FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.
    Selkoe DJ
    Behav Brain Res; 2008 Sep; 192(1):106-13. PubMed ID: 18359102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.
    Ettcheto M; Busquets O; Cano A; Sánchez-Lopez E; Manzine PR; Espinosa-Jimenez T; Verdaguer E; Sureda FX; Olloquequi J; Castro-Torres RD; Auladell C; Folch J; Casadesús G; Camins A
    J Alzheimers Dis; 2021; 82(s1):S91-S107. PubMed ID: 33325386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of AMPA receptor trafficking at hippocampal synapses by beta-amyloid oligomers: the mitochondrial contribution.
    Rui Y; Gu J; Yu K; Hartzell HC; Zheng JQ
    Mol Brain; 2010 Mar; 3():10. PubMed ID: 20346152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer's Disease Treatment.
    Zhang H; Sun S; Wu L; Pchitskaya E; Zakharova O; Fon Tacer K; Bezprozvanny I
    J Neurosci; 2016 Nov; 36(47):11837-11850. PubMed ID: 27881772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuronal Rho GEFs in synaptic physiology and behavior.
    Miller MB; Yan Y; Eipper BA; Mains RE
    Neuroscientist; 2013 Jun; 19(3):255-73. PubMed ID: 23401188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
    Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
    Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oridonin Attenuates Synaptic Loss and Cognitive Deficits in an Aβ1-42-Induced Mouse Model of Alzheimer's Disease.
    Wang S; Yu L; Yang H; Li C; Hui Z; Xu Y; Zhu X
    PLoS One; 2016; 11(3):e0151397. PubMed ID: 26974541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MMP-9 Signaling Pathways That Engage Rho GTPases in Brain Plasticity.
    Figiel I; Kruk PK; Zaręba-Kozioł M; Rybak P; Bijata M; Wlodarczyk J; Dzwonek J
    Cells; 2021 Jan; 10(1):. PubMed ID: 33467671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enlarged dendritic spines and pronounced neophobia in mice lacking the PSD protein RICH2.
    Sarowar T; Grabrucker S; Föhr K; Mangus K; Eckert M; Bockmann J; Boeckers TM; Grabrucker AM
    Mol Brain; 2016 Mar; 9():28. PubMed ID: 26969129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Withdrawal from repeated morphine administration augments expression of the RhoA network in the nucleus accumbens to control synaptic structure.
    Cahill ME; Browne CJ; Wang J; Hamilton PJ; Dong Y; Nestler EJ
    J Neurochem; 2018 Oct; 147(1):84-98. PubMed ID: 30071134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model.
    Diniz LP; Tortelli V; Matias I; Morgado J; Bérgamo Araujo AP; Melo HM; Seixas da Silva GS; Alves-Leon SV; de Souza JM; Ferreira ST; De Felice FG; Gomes FCA
    J Neurosci; 2017 Jul; 37(28):6797-6809. PubMed ID: 28607171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.